Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrine Diseases
    • Gastrointestinal Conditions
    • General Indications
    • Hematology
    • Hereditary Genetic Disorders
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Nephrologic/Hepatologic Conditions
    • Neurological Diseases
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Perspective
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search

    Sorry, something went wrong. Please try your search again.
    ×

    • Articles
    • Blog posts

RSS Feed

Enter the URL below into your favorite RSS reader.

https://jheor.org/feed
×
Methodology and Healthcare Policy
Vol. 1, Issue 3, 2014February 26, 2016 EDT

The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures

Zeynal Karaca, Steven N. Wiggins,
meps prescription drugs healthcare expenditures drug classes
Copyright Logoccby-4.0
Photo by Haley Lawrence on Unsplash
JHEOR
1.
Karaca Z, Wiggins SN. The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures. JHEOR. 2016;1(3):276-295.
Save article as...▾
  • PDF
  • XML
  • Citation (BibTeX)

View more stats

Powered by Scholastica, the modern academic journal management system